Medical Xpress December 11, 2024
Cancer researchers at Fox Chase Cancer Center in Philadelphia see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.
Pancreatic cancer accounts for 3% of all cancers and a disproportionate 7% of cancer deaths. That’s partly because there’s no routine screening to test for the disease whose symptoms can be mistaken as indigestion or the flu. As a result, pancreatic cancer is often not detected until it has spread to other organs and become more difficult to treat.
But researchers are increasingly learning how each person’s cancer is unique and how to tailor treatment to their disease’s profile. They are also finding genetic links to pancreatic cancer that could help detect...
Today's Sponsors
Today's Sponsor